Booming AIE universe has set off an upsurge in recent years, driving much innovation in academic, industrial and medical world. Superb reliability and biocompatibility equip AIE dots with tremendous potential for fluorescence bioimaging and even clinical translation. The utilization on non-human primates imaging are vital for AIE dots assisted clinical theranostics, which still remains unexplored yet. Additionally, fluorescence bioimaging in second near-infrared window (NIR-II, 900-1700 nm) is widely recognized as an effective technology for deep-penetration mammals optical imaging. Here, we designed a novel AIEgen with a large molar extinction coefficient of ~5×104 mM−1 cm−1 at ~770 nm and the PEGylated AIE dots possessed an extremely high NIR-II photoluminescence quantum yield (PLQY) as 13.6%, exhibiting bright fluorescence beyond 1100 nm and even 1500 nm (near-infrared IIb, NIR-IIb). Assisted by the AIE dots, large-depth cerebral vasculature (beyond 600 μm) as well as real-time blood flowing were monitored through the skull and high-spatial-frequency non-invasive NIR-IIb (beyond 1500 nm) imaging gave a precise presentation of gastrointestinal tract in marmosets. Importantly, after intravenous or oral administration, the definite excretion of AIE dots from the body was demonstrated. It was the first attempt for AIE dots assisted NIR-II fluorescence imaging in non-human primates and we wished this work could promote the development of AIE dots for clinical application.